Track the 모아라이프플러스 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 모아라이프플러스 has published 30 insider filings. Market capitalisation: €19.2bn. The latest transaction was disclosed on 9 July 2026 (Other). Among the most active insiders: 모아데이타. Every trade is accessible without an account.
30
Insider Decl.
n/a
Thresholds
n/a
5 ops.
Buy Volume
n/a
4 ops.
Sell Volume
19Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 28,352 of 29,063 companies
11.0
score / 100
Value
6
Quality
17
FCF yld-30%
Earn yld-63%
EV/EBITDA·
ROE-22%
Gross mgn17%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
모아라이프플러스 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX. It focuses on developing innovative solutions to enhance patients' quality of life.